Other cancer types, including breast cancer, lung adenocarcinoma, lung squamous cell carcinoma, melanoma, ovarian, pancreatic, and prostate cancers, had higher CMTM4 expression levels, which is consistent with our data (Fig. 1A,B). This evidence concerns the gene CMTM4 and prostate cancer.